作者
Paolo Giorgini, Paolo Di Giosia, Davide Grassi, Melvyn Rubenfire, Robert D Brook, Claudio Ferri
发表日期
2016/1/1
来源
Current pharmaceutical design
卷号
22
期号
1
页码范围
28-51
出版商
Bentham Science Publishers
简介
Both high arterial blood pressure (BP) and elevated levels of fine particulate matter (PM2.5) air pollution have been associated with an increased risk for several cardiovascular (CV) diseases, including stroke, heart failure, and myocardial infarction. Given that PM2.5 and high BP are each independently leading risk factors for premature mortality worldwide, a potential relationship between these factors would have tremendous public health repercussions. Therefore, the aim of this review is to summarize recent evidence linking air pollution and BP. Epidemiological findings demonstrate that particulate pollutants cause significant increases in BP parameters in relation to both short and long-term exposures, with robust evidence for exposures to PM2.5. Moreover, recent epidemiological studies suggest a positive association between residence within regions with higher levels of ambient PM and an increased …
引用总数
201620172018201920202021202220232024112424433847454014
学术搜索中的文章
P Giorgini, P Di Giosia, D Grassi, M Rubenfire… - Current pharmaceutical design, 2016